MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$44,207K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales and maturities of marketab...
Equity-based compensation
Prepaid and other assets
Others
Negative Cash Flow Breakdown
Net loss before noncontrolling i...
Purchases of marketable securiti...
Purchase of equipment and facili...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss before noncontrolling interest
-46,436
-42,621
-40,852
-35,843
Depreciation and amortization
1,678
1,658
1,837
1,673
Equity-based compensation
5,594
4,945
5,703
6,676
Gain on marketable securities, net
256
413
743
732
Loss on lease disposition
143
-
-
0
Gain on lease disposition
-
-
29
-
Impairment charges
-
-
0
318
Loss on disposal of equipment
0
0
-957
-10
Interest receivable
-76
-95
-110
-538
Prepaid and other assets
-1,678
-609
1,559
-593
Accounts payable and accrued expenses
-2,708
-5,957
2,156
51
Income taxes payable
0
0
50
120
Net cash flows used in operating activities
-40,374
-41,684
-32,513
-26,596
Proceeds from sale of facility
-
-
18,215
-
Purchases of marketable securities
32,035
44,754
40,400
78,538
Sales and maturities of marketable securities
48,674
83,366
56,030
112,753
Purchase of equipment and facility expansion
3,833
3,785
5,752
5,197
Net cash flows provided by investing activities
12,806
34,827
28,093
29,018
Proceeds from sales of class a ordinary shares, net of offering costs
0
7
17,145
7,102
Payments on finance leases
5
3
5
-5
Exercise of stock options
546
211
494
854
Repurchase of class a common stock amount
-
-
0
-
Net cash flows (used in) provided by financing activities
541
215
17,634
7,961
Net change in cash and cash equivalents
-27,027
-6,642
13,214
10,383
Cash, beginning of period
101,895
108,537
95,323
99,120
Cash, end of period
74,868
101,895
108,537
95,323
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Sales and maturities
of marketable...
$48,674K
(-67.39%↓ Y/Y)
Exercise of stock options
$546K
Net cash flows
provided by investing...
$12,806K
(-72.67%↓ Y/Y)
Net cash flows (used
in) provided by...
$541K
(2180.77%↑ Y/Y)
Canceled cashflow
$35,868K
Canceled cashflow
$5K
Net change in cash
and cash...
-$27,027K
(-90.60%↓ Y/Y)
Canceled cashflow
$13,347K
Equity-based compensation
$5,594K
(-56.83%↓ Y/Y)
Prepaid and other assets
-$1,678K
(76.70%↑ Y/Y)
Depreciation and
amortization
$1,678K
(-45.25%↓ Y/Y)
Interest receivable
-$76K
(88.69%↑ Y/Y)
Purchases of marketable
securities
$32,035K
(-67.36%↓ Y/Y)
Purchase of equipment and
facility expansion
$3,833K
(-9.75%↓ Y/Y)
Payments on finance
leases
$5K
(-80.77%↓ Y/Y)
Net cash flows used
in operating...
-$40,374K
(33.82%↑ Y/Y)
Canceled cashflow
$9,026K
Net loss before
noncontrolling interest
-$46,436K
(38.02%↑ Y/Y)
Accounts payable and
accrued expenses
-$2,708K
(66.67%↑ Y/Y)
Gain on marketable
securities, net
$256K
(-86.82%↓ Y/Y)
Buy us a coffee
PROKIDNEY CORP. (PROK)
PROKIDNEY CORP. (PROK)